Creating more beds and boosting immunisation are key features of a $140 million "winter strategy" aimed at avoiding a repeat ...
For the first time, the Arexvy® RSV vaccine, which typically costs around $300 privately, will be made available at no cost to all people aged 65 and over in residential aged care homes. This program ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results